TCR2 Therapeutics Inc. (TCRR)
NASDAQ: TCRR
· Real-Time Price · USD
1.48
0.00 (0.00%)
At close: May 31, 2023, 10:00 PM
TCR2 Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -165.8M | -153.5M | -119.66M | -114.79M | -107.31M | -99.7M | -90.69M | -81.64M | -74.07M |
Interest Income | 2.93M | 1.94M | 963K | 491K | 193K | 76K | 229K | 491K | 990K |
Pretax Income | -162.87M | -151.56M | -118.73M | -114.34M | -107.13M | -99.52M | -90.31M | -81M | -72.96M |
Net Income | -163.1M | -151.82M | -119.06M | -114.71M | -107.42M | -99.81M | -90.52M | -81.2M | -73.13M |
Selling & General & Admin | 26.32M | 24.44M | 23.84M | 23.49M | 23.16M | 22.5M | 21.57M | 19.97M | 18.12M |
Research & Development | 105.56M | 99.18M | 95.85M | 91.34M | 84.2M | 77.24M | 69.13M | 61.67M | 55.95M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 131.88M | 123.62M | 119.69M | 114.83M | 107.35M | 99.74M | 90.69M | 81.64M | 74.07M |
Interest Expense | 7.27M | 415K | 415K | 415K | 117K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 131.88M | 123.62M | 119.69M | 114.83M | 107.35M | 99.74M | 90.69M | 81.64M | 74.07M |
Income Tax Expense | 228K | 261K | 325K | 366K | 289K | 289K | 204K | 193K | 170K |
Shares Outstanding (Basic) | 39.22M | 38.81M | 38.62M | 38.57M | 38.51M | 38.29M | 38.2M | 38.18M | 37.06M |
Shares Outstanding (Diluted) | 39.22M | 38.81M | 38.62M | 38.57M | 38.51M | 38.29M | 38.2M | 38.18M | 37.06M |
EPS (Basic) | -4.2 | -3.93 | -3.09 | -2.99 | -2.81 | -2.63 | -2.46 | -2.33 | -2.36 |
EPS (Diluted) | -4.2 | -3.93 | -3.09 | -2.99 | -2.81 | -2.63 | -2.46 | -2.33 | -2.36 |
EBITDA | -95.75M | -91.43M | -116.5M | -111.72M | -104.22M | -96.69M | -87.86M | -78.88M | -71.16M |
EBIT | -156.53M | -152.07M | -118.83M | -113.96M | -107.08M | -99.7M | -72.13M | -45.88M | -21.59M |
Depreciation & Amortization | 70.06M | 62.07M | 3.15M | 3.03M | 3.02M | 2.83M | 2.45M | 2.12M | 1.8M |